Read previewWith the Ozempic craze in full swing, investors are getting picky about the weight-loss startups they want to back.
Kaganoff predicted that in the new year some startups prescribing GLP-1s would invest more money in studies using real-world evidence to show their programs work.
And despite the Ozempic frenzy, weight-loss startups captured a tiny fraction of the money invested this year.
Investors had put about $211 million toward weight-loss startups through mid-November, representing about 3% of digital-health funding over that period, according to PitchBook.
Alfie HealthSome unlikely sectors of the healthcare industry stand to benefit from the growth of the weight-loss market.
Persons:
—, Sari Kaganoff, Crystal Cox, Kaganoff, Ro, VCs, Michael Greeley, Alyssa Jaffee, 7wireVentures, she's, she'd, Mounjaro, Mercer, Michael Siluk, PitchBook, Alfie Health, it's, Alfie's cofounders, Aaron DeGagne, Jordan, he'd, DeGagne, There's
Organizations:
Service, Business, Rock Health, Flare Capital Partners, Getty, Employers, Health, Investors, Phenomix Sciences, Mayo Clinic, PitchBook, Tusk Venture Partners, Sword Health
Locations:
GLP